Abstract
Introduction
Arthritis is one of the most common forms of slowly progressive, systemic, autoimmune inflammatory disorders of synovial joints which affect ~2% of adult population worldwide [1] [2] [3] [4] .
This progressive degenerative disease is characterized by uncontrolled proliferation of tissue in the inner layer of the synovial membrane leading to chronic joint inflammation [1, 3, 4] . This in turn leads to restricted joint mobility and partial disability and thereby severely affects the quality of life of the affected population. If synovial inflammation is left untreated, it can even lead to loss of cartilage, erosion and weakening of bones. The treatment strategy involves ablation of diseased synovial membranes followed by the regeneration of disease-free synovium which eventually results in the reduction of inflammation in the joints, alleviation of the pain, improvement in mobility and preservation of joint functions [1] . Ablation of the synovium can be accomplished through a number of surgical and non-surgical procedures including laser surgery, use of chemicals such as osmic acid rifampicin, and use of inoizing radiation by intraarticular administration of β -emitting radionuclides in suitable chemical formulation. Among all these treatment modalities in practice, intra-articular administration of β -emitting radionuclides in the form of colloidal formulation or radiolabeled particulate (preferably of 1-10 µm size range) into the articular cavity, referred as 'radiation synovectomy (RSV)' or 'radiosynoviorthesis', has emerged as one of the most effective option having satisfactory clinical efficacy and minimum side-effects [2] [3] [4] [5] [6] [7] [8] [9] .
While a myriad of factors contribute to the utility of RSV, selection of an appropriate β -emitting radionuclide of optimum tissue penetration range along with desirable radioactive decay characteristic is a key determinant that underpins its success. The β -radiation energy should be sufficient to penetrate and ablate proliferating layer of the inflamed synovium with minimum radiation induced damaged to the underlying articular cartilage or adjacent bone underneath [5, [10] [11] [12] . The radionuclide should have a half-life adequate to deliver cytotoxic radiation dose to the synovium and at the same time should be substantially less than the retention time of the radiolabeled formulation in the joint to be treated. Among the various radionuclides used for RSV, the lanthanide radionuclides such as, 90 Y (yttrium is considered as a pseudo-lanthanide), 153 Sm, 165 Dy, 166 Ho, 169 Er, 175 Yb and 177 Lu (Table 1 ) have dominated the field significantly and have been profusely explored for the development of a broad panoply of radiolabeled particles/colloids/macroaggregates [2, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . This is principally due the availablity of a wide variety of therapeutically useful β -emitting radionuclides among lanthanide elements having a wide range of energy (0.34-2.28 MeV). As the thickness of the proliferating membrane varies in different joints, treatment of diseased synovium in joints of disparate size requires radionuclide of different β -particles energies. In this premise, the scope of using a single carrier platform loaded with different lanthanide radionuclides resulting in a series of radiolathnanide-loaded particulates of same material would be an interesting proposition. This is expected to pave the way for the treatment of arthritis of human joints of different sizes from finger joint than for a knee, for example, by selecting particlutae loaded with the suitable lathanide radionuclide. In pursuit of such a strategy, the possibility of using 90 Y, 153 Sm, 166 Ho, 169 Er and 177 Lu seemed attractive as they offer the prospect of designing radiolabeled particles of wide spectrum of β -particle energies.
In the quest of an innovative and more effective carrier platform to deliver cytotoxic dose of radiolathnades to the diseased synovium, our attention was turned toward use of nanomaterials as they provided unprecedented opportunities to design and synthesis of novel materials which preferentially target proliferating cells in biological systems [25, 26] . While the usefulness of iron 5 oxide nanoparticles as the platform to deliver imaging probes including radionuclides and therapeutic drugs [27] [28] [29] [30] [31] [32] and in hyperthermia therapy [27, [33] [34] [35] [32, 36] .
In the present study, we have adopted similar strategy in synthesizing radiolanthanide Sr activities during EPC studies were carried out using liquid scintillation counter. All other radioactivity measurements were carried out by using a well type NaI(Tl) scintillation counter (Mucha, Raytest, Germany).
Xylazine hydrochloride and ketamine hydrochloride used for anaesthetizing the animals during animal were procured from local suppliers. Bioluminiscence images of the animals after administration of the radiolabeled preparation were recorded using Photon Imager (Biospace Lab, France). All the animal experiments were conducted in strict compliance of the relevant national laws relating to the conduct of animal experiments in India.
Synthesis of agglomerated Fe 3 O 4 nanoparticles (Agl-MNP)
Aqueous solutions of ferric chloride (0.1 M, 20 mL) and ferrous sulphate (0.1 M, 10 mL)
were mixed with stirring. The resultant solution was made alkaline by addition of 20 mL of 0.2 M NaOH. The black precipitate evolved was separated using a magnet, washed five times with water and dried after stirring for 1 hour. The preciptate was further dried using acetone.
Subsequently, 1 g of Fe 3 O 4 obtained was treated with 10 mL of 0.1 M NaHCO 3 . This process leads to the formation of highly agglomerated nanoparticles of Fe 3 O 4 , which gradually settles in aqueous medium.
Physicochemical characterization
The prepared samples of Agl-MNP were characterized using X-ray diffractometry (using Rigaku Miniflex 600 X-ray diffractometer) and crystallite size (t) was calculated using the The X-ray photoelectron spectroscopy (XPS) spectra were recorded in a UHV chamber (base pressure < 2 × 10 -8 mbar) using a VG CLAM-2 analyzer with a nonmonochromatic twin Mg Xray (hν ~ 1253.6 eV) source. All binding energies were referenced to the C1s peak at 284.6 eV. Sr/ 90 Y generator system developed in-house [37] . Y-90
Production and quality control of radionuclides
is obtained as 90 YCl 3 solution in 0.1 N HCl from this generator following the procedure reported earlier [37] , which was subsequently used.
The total activty of all the radionuclides produced was individually assayed using gamma ray spectrometry using HPGe detector coupled to a 4K-MCA system, except that of 90 Y. Energy and efficiency calibration of the detector was carried out using standard 152 Eu and 133 Ba sources of the same geometry as the test samples. Prominent photo peak/s of the radionuclides (Table 1) were used for measurements of the radioactivity content. The activity of 90 Y produced was determined using a pre-calibrated liquid scintillation counter. For the determination of radionuclidic purity, the trace level of co-produced gamma emitting radionuclide impurities were assayed by recording the gamma ray spectra of the sample aliquot from the batch processed, initially having high radioactive concentration, after complete decay ( constant stirring at room temperature. Subsequently, the susupended particlualtes were allowed to settled at the bottom of the reaction tube and the supernatant was carefully separated.
Optimization of protocol for formulation of radiolanthanide-loaded Agl-MNPs
The *Ln-loaded particles thus obtained were subjected to a further washing using 1 mL of sterile 0.9% saline to ensure the removal of unlabeled [*Ln +3 ] activity, if any. Finally, the radiolanthanide-loaded particulates were suspended in sterile 0.9% and autoclaved.
Several experiments were carried out by varying the reaction parameters such as, concentration of particles, pH of the reaction mixture and mixing time etc in order to obtain the optimized protocol for maximum yield of radiolabeled particles. In a reaction volume of 1 mL, the amount of particles was varied between 1 mg to 10 mg and the radiolabeling yield was determined in each case. The effect of variation of pH on radiolabeling yield at room temperature was studied by adjusting the pH of the reaction mixture to different from 2 to 10 using either 1 M HCl or 1 M NaOH solutions. The mixing time required to obtain maximum labeling yield was optimized by carrying out reactions for different time periods (0, 10, 20, 30, 60 and 120 min) at room temperature and determining the yield in each case.
Determination of yield and radiochemical purity
The loading yields of radiolanthanides on Agl-MNP were determined in the following
way. An aliquot (typically, 20 µL) was withdrawn from the supernatant solution of reaction mixture after the precipitation of Agl-MNP and the radioactivity was measured. Same aliquot was withdrawn from 'blank' (solution having the identical composition of *Ln-Agl-MNP reaction mixture without particles) and the activity was measured. Percentage radiochemical yield was determined from the activity data using the following formula:
where, B and R are the background-corrected *Ln activities associated with the aliquots withdrawn from the blank and supernatant solution of the reaction mixture, respectively. The radiochemical purity of the radiolabeled preparation was determined using the same technique subsequent to the removal of unlabeled *Ln activity by washing of loaded Agl-MNP using normal saline.
In vitro stability studies
In vitro stability of radio-lanthanide loaded Agl-MNPs was studied in normal saline. For this, loaded particles were suspended in 1 mL of normal saline. The suspensions were stored at 37 °C up to 3 half-lives of the individual radionuclide. The radiochemical purities of the suspended *Ln-Agl-MNPs were determined at the end of different time intervals by following the technique described previously. The in vitro stability of the radiolabeled particulates was also ascertained by DTPA challenge (DTPA = Diethylene Triamine Pentacaetic Acid). For this, the radiolabeled formulation was suspended in 1 mL of 5 mM aqueous solution of DTPA (pH ~6.5) and the mixture was stored at room temperature. The percentage radiochemical purity *Ln-AglMNPs in presence of strong chelator DTPA was determined at regular time intervals upto 48 h of storage following the same technique as described above.
Synthesis of cold Y/Ho-Agl-MNPs
Agl-MNP (50 mg) was suspened in 4 mL of 0.1 M NaHCO 3 solution. To this suspension, 1 mL of YCl 3 /HoCl 3 solution in 0.01 M suprapure HCl containing 50 mg of yittrium/holmium was added and it was mixed thoroughly at room temperature for 24 h using magnetic stirrer. The pH of the mixture was found to be ~7-8. Subsequently, the mixture was centrifuged and supernatant was removed carefully. The precipitated Y/Ho-loaded particles were washed thrice with de-ionized water and dried under IR lamp. Subsequently, these particulates were analysed by SEM and EDX techniques.
SEM and EDX analyses
The surface morphology and particle size distribution of Y/Ho-loaded Agl-MNPs were examined using SEM (AIS2100 SERON Technologies, South Korea). For SEM analysis powder samples were spread over mirror polished Si substrate using acetone, dried and tapped to remove any loose particle prior to loading into SEM chamber. All the micrographs were recorded at the same magnification so as to compare the size and shape of samples. Elemental analyses were carried out using the same samples by EDX technique.
In vivo studies in animal model
The pre-clinical biological evaluation of 90 Y-and 166 Ho-loaded Agl-MNPs was studied by carrying out bio-distribution and radio-luminescence imaging studies in normal Wistar rats.
Radio-luminescence imaging (also known as Cerenkov luminescence imaging) technique is based on the emission of visible light during the passage of particulate radiation from the decay of cetrain radionuclides therough the condensed phase (that of biological tissue in the present case) [39] . For biodistribution studies, loaded particles (~2 MBq) suspended in 100 µL of normal saline was injected intra-articularly into one of the knee joints of each animal. For intra-arterial administration, the rats were first anaesthetized using a combination of xylazine hydrochloride and ketamine hydrochloride. Subsequently, the left knee area of the animals was clipped and obtaining the total skeletal uptake assuming skeletal weight to be 10% of the total body weight [21, 22] . The total uptake in blood, skeleton and muscle were calculated by considering that the respective tissue constitute 7%, 10% and 40% of the total body weight [21, 22] . The percentage of activity excreted is indirectly ascertained by subtracting the activity accounted in all the organs from the total injected activity. For radio-luminescence imaging, 90 Y-and 166 Ho-Agl-MNP preparations (~ 10 MBq) suspended in 100 µL of normal saline were injected into the joints. Prior to the acquisition of images, the animals were anesthetized using a combination of xylazine hydrochloride and ketamine hydrochloride. Sequential whole-body radio-luminescence images were acquired in Photon Imager at the same time points p.i. when the bio-distribution studies were carried out.
All animal experiments were performed in compliance with the relevant laws and institutional guidelines of the Bhabha Atomic Research Centre, and also state that the institutional Animal Ethics Committee has approved the experiments.
Results
The primary objective of this investigation aims at developing a synthetic route for the large scale preparation of agglomerated Fe 3 O 4 nanoparticles, structural characterization of the material, and evaluation of its usefulness as a viable carrier platform for the preparation of radiolanthanide-loaded particles for use in RSV. With a view to accomplish the desired goal, a systematic approach was pursued.
Synthesis and characterization of agglomerated Fe 3 O 4 nanoparticles
The schematic diagram for formation of agglomerated Fe 3 O 4 nanoparticles is shown in X-ray diffraction (XRD) pattern shows cubic structure of Fe 3 O 4 with lattice parameter a = 8.38 Å (Fig. 2(i) ), which is matching with the reported value [40] . Fourier transform infrared (FTIR) spectra of Fe 3 O 4 particles before and after treatment with NaHCO 3 suggest that both have Fe-O characteristic peak at 600 cm -1 (Fig. 2(ii) ) [41] . Additionally, surface -OH groups on Fe 3 O 4 particles were identified by characteristic peaks at 3400 (stretching) and 1650 cm -1 the peak at 3400 cm -1 . This observation is probaly attributed to the formation of O -:Na + ion-pair on the surface of the particles. This will lead to negative surface charge on the particles and expected separation of the particles. However, magnetic dipole-dipole interaction might have dominated over electrostatic separation force resulting in the agglomeration of smaller crytallites.
The peak at 1640 cm -1 will be related to the carbonate residue from NaHCO 3 solution. TEM image of Fe 3 O 4 particles shows the highly agglomerated particles (Fig. 2(iii) ) and its selected area electron diffraction (SAED) pattern ( Fig. 2(iv) ) suggests the highly crystalline phase with the cubic structure.
Since has an extra peak (known as satellite) at 719 eV [42] . It is concluded that our prepared compound is Fe 3 O 4 . The position of O 1s peak is found at 530 eV, which is similar to the reported one [42] .
However, there is asymmetric nature in peak at higher binding energy side. This is suggested that oxygen stoichiometry is not maintained. This is due to inhomogeneity of oxygen at core as well as surface of nanoparticles.
Production and quality control of the radionuclides
The specific activity and radionuclidic purity of the radionuclides produced in the reactor at 6 h after the end of irradiation (EOI) are shown in 
Formulation of radiolanthanide-loaded agglomerated Fe 3 O 4 nanoparticles
With an aim to arrive at the optimum conditions for formulation of radiolanthanide AglMNPs with maximum yield, a detailed study on the influence of various experimental parameters on the radiolabeling yield were carried out. All the optimization studies were carried out using ~185 be considered as the clinically relevant doses for treatment of arthritis for various joints [10] . The effect of variation of the concentration of Agl-MNP on the yield of each of the radiolanthanide loaded Agl-MNP is shown in Fig. 4 . In all the cases reactions were carried out at pH ~7 for 30 min at room temperature. It was found that while NCA 90 Y-loaded Agl-MNP could be prepared in high yield of 96.4 ± 0.8% using 2 mg particles in 1 mL reaction volume, for other radionuclides including (n,γ) produced 90 Y, the minimum amount of particles required for obtaining >95% yield was 5 mg. Consequently, 5 mg/mL was considered as the optimum particulate concentration for formulation of clinically relevant doses of radiolanthanide loaded particulates. Variation of pH of the reaction mixture between 2 to 10 showed that the pH did not have any significant effect on the yield within the range of 5-10. Below pH 5, the yields were found to be poor. The optimum pH for formulation of radiolanthanide loaded particlulates was therefore considered to be ~7-8, which is advantageous as it is close to the physiological pH.
Further, it was found that when the reaction was carried out in 0.1 M NaHCO 3 medium, the pH was automatically adjusted within 7-8 when * Fig. 1 .
In vitro stability studies
Radiolanthanide-loaded Agl-MNPs showed excellent in vitro stability upto a study period of ~3 half-lives of respective lanthanide radionuclides when stored in normal saline at 37 °C. The radiochemical purities of all the preparations were found to retain to the extent of >98% during the entire study period. In the DTPA challenge study, it was observed that the radiochemical purities of all the preparations under investigation gradually degraded in 5 mM DTPA solution as shown in Fig. 5 . This gradual degradation is most likely due to leaching of lanthanide ions from the loaded particles and formation of Ln-DTPA complex. However, it is pertinent to note that the radiochemical purities of the loaded particulates were found to retain to the extent of >70% even after 48 h of storage, even when they were challenged by strong chelator DTPA present in concentration as high as 5 mM. This indicates fairly strong chemical association of lanthanides with particles, an essential prerequisite in designing radiotherapeutic agents for radiation synovectomy.
SEM and EDX analyses of Ho-loaded Fe 3 O 4 particles
A typical scanning electron micrograph of holmium labelled Agl-MNP is shown in Fig.   6 . The SEM result reveals that the particles have porous architecture throughout the matrix. The porous surface has an advantage because it can facilitate the diffusion of lanthanide for adsorption on the internal surface of the particulates. The micrograph also revealed that the size of holmium laoded particles were ranged from 1-10 µm.
To verify the elemental composition and ensure the incorpotation of Ho into the matrix, an EDX profile of holmium loaded particles have also been recorded as shown in Fig. 7 . determined from the intensity of the peak pertaining to different elements and the quantification of results is given in Table 3 .
In vivo studies in animal model
The results of the bio-distribution studies carried out in normal Wistar rats after loco- 
Discussion
The role of RSV as a safe, minimally invasive and cost effective therapeutic option in the management of different kinds of arthritis needs hardly to be reiterated [43] . The progress in this radiotherapeutic modality has been largely due to availability of more potent radioactive agents.
The biological mechanism of RSV essentially involves the absorption of radioactive particulates by superficial cells of the synovium followed by phagocytosis by the macrophages of the inflamed synovium. Beta radiation results coagulation necrosis, fibrosis and sclerosis of the proliferating synovial tissue and leads to destruction of diseased pannus and inflamed synovium [3, 5, 8, 9] . This prevent the secretion of fluid and accumulation of inflammation causing cellular compounds and the joint surfaces become fibrosed, offering rapid and sustain pain relief. The effective cytotoxic radiation dose required to be delivered to the joints is determined principally by the size of the joint along with other factors such as synovial thickness, synovial structures (smooth, villous-fine/rough edematous),condition of the joint fluid (watery or gelatinous) and inflammatory activity of synovium.
The exciting perspective of radiolanthanides in RSV is primarily attributed to their ideally suited nuclear decay properties, favorable production logistics and avavilability of biocomatible materials where lanthnides can be irreversibly loaded. Table 1 gives the list of such radionuclides with their decay properties and the routes of their production. The selection of a radiolanthanides for a specified application is primarily dictated by the physical half live, the mean tissue penetration range of the emitted β -particles and the size of the joint to be treated.
The penetration depth of the β -radiation energy should correspond to the thickness of the synovium in the joint to be treated as inadequate penetration will give an inferior therapeutic effect, and excessive penetration would lead to radiation dose to healthy tissue. The inherent success of RSV also reside on the selection an effective particulate carrier for the radionuclide. The particle used in RSV should be biocompatible, non-toxic, preferably biodegradable and have surface sites that allow absorption or binding of the radionuclide. The binding between the radionuclide and the particle should be essentially irreversible through the course of radiotherapy in order to prevent the leakage of radioactive material from the joint and to avoid whole-body radiation and its systemic effects. Our interest on the use of iron oxide nanoparticles spawned from its inimitable physicochemical characteristics including low toxicity, chemical inertness, biocompatibility, and possibility of surface functionalization for absorption/binding of metal ions [27, 30] . Iron oxide nanoparticles are clinically approved metal oxide nanoparticles and have been shown to be associated with low toxicity in the human body [44] . Recent studies reported with supermagnetic iron oxide nanoparticles showed that the administered naoparticles were gradually degraded form the organs and biotransformed into poorly magnetic iron species, which were believed to be stored into ferritin proteins over a period of three months [45, 46] .
Owing to large surface-to volume ratio, iron oxide nanoparticles possess high surface energies and thus tend to aggregate so as to minimize the surface energies. The agglomeration tendency offer the scope for preparing agglomerated Fe 3 O 4 nanoparticles of 1-10 µm size range.
While a number of strategies for radiolabeling of Fe 3 O 4 nanoparticle have been reported, chelator free radiolabeling by noncovalent physisorption appeared to be enticing and the least intricate route [34, 38] . This strategy has been successfully followed in the present work. Fe 3 O 4 nanoparticle exhibits intrinsic surface reactivity and in aqueous solution coordinated with water to bear surface hydroxyl groups [47] . These reactive -OH groups on subsequent dissociation generate ion pair (-O-:Na + ) when these particles are dispersed in NaHCO 3 solution at pH = 7.
The ion pair ( 
